SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-20-013332
Filing Date
2020-05-22
Accepted
2020-05-22 16:28:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea122244-424b3_adialpharma.htm 424B3 360056
2 GRAPHIC logo.jpg GRAPHIC 20748
3 GRAPHIC img_001.jpg GRAPHIC 108341
  Complete submission text file 0001213900-20-013332.txt   539295
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220368 | Film No.: 20906302
SIC: 2834 Pharmaceutical Preparations